Watch for Cabenuva, a New Monthly Injectable for HIV

March 2021

Cabenuva (cabotegravir/rilpivirine) will be the first MONTHLY antiretroviral treatment for adults living with HIV.

It's given as two IM gluteal injections at the same visit. Each Cabenuva kit has one vial of cabotegravir, an integrase inhibitor...and one vial of rilpivirine, a non-nucleoside reverse transcriptase inhibitor.

Explain that viral load suppression with Cabenuva seems similar to standard 3-med oral DAILY regimens, such as Biktarvy or Triumeq.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote